NCT03764449View on ClinicalTrials.gov

A Study Investigating the Absolute Oral Bioavailability of Balovaptan After Single and Multiple Daily Oral Doses of Balovaptan in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

March 4, 2019

Study Completion Date

March 15, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

Oral Balovaptan

"In Period 1, balovaptan was administered as a single oral dose.~In Period 2, balovaptan was administered as an oral dose once daily on Day 1 to Day 14."

DRUG

IV Balovaptan

"In Period 1, IV infusion of balovaptan was administered after the balovaptan oral dose.~In Period 2, IV infusion of balovaptan was administered after the final oral dose of balovaptan."

Trial Locations (1)

9728 NZ

Pra International Group B.V, Groningen

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT03764449 - A Study Investigating the Absolute Oral Bioavailability of Balovaptan After Single and Multiple Daily Oral Doses of Balovaptan in Healthy Volunteers | Biotech Hunter | Biotech Hunter